Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Upadacitinib

    Virtual Booth

    Contact Supplier

    Upadacitinib

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Upadacitinib

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Upadacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4ABBVIE

    02 2AUROBINDO PHARMA LTD

    03 2SANDOZ INC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    ABBVIE

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    UPADACITINIB

    Brand Name : RINVOQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 15MG

    Approval Date : 2019-08-16

    Application Number : 211675

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ABBVIE

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    UPADACITINIB

    Brand Name : RINVOQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 30MG

    Approval Date : 2022-01-14

    Application Number : 211675

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ABBVIE

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    UPADACITINIB

    Brand Name : RINVOQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 45MG

    Approval Date : 2022-03-16

    Application Number : 211675

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ABBVIE

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    UPADACITINIB

    Brand Name : RINVOQ LQ

    Dosage Form : SOLUTION;ORAL

    Dosage Strength : 1MG/ML

    Approval Date : 2024-04-26

    Application Number : 218347

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    AUROBINDO PHARMA LTD

    India
    PEGS Boston Summit
    Not Confirmed
    arrow

    AUROBINDO PHARMA LTD

    India
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    UPADACITINIB

    Brand Name : UPADACITINIB

    Dosage Form : TABLET;ORAL

    Dosage Strength : 15MG

    Approval Date :

    Application Number : 218866

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    AUROBINDO PHARMA LTD

    India
    PEGS Boston Summit
    Not Confirmed
    arrow

    AUROBINDO PHARMA LTD

    India
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    UPADACITINIB

    Brand Name : UPADACITINIB

    Dosage Form : TABLET;ORAL

    Dosage Strength : 30MG

    Approval Date :

    Application Number : 218866

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    SANDOZ INC

    Switzerland
    PEGS Boston Summit
    Not Confirmed
    arrow

    SANDOZ INC

    Switzerland
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    UPADACITINIB

    Brand Name : UPADACITINIB

    Dosage Form : TABLET, EXTENDED RELEASE

    Dosage Strength : 30MG

    Approval Date :

    Application Number : 218792

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    SANDOZ INC

    Switzerland
    PEGS Boston Summit
    Not Confirmed
    arrow

    SANDOZ INC

    Switzerland
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    UPADACITINIB

    Brand Name : UPADACITINIB

    Dosage Form : TABLET, EXTENDED RELEASE

    Dosage Strength : 15MG

    Approval Date :

    Application Number : 218792

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.